Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study
Authors:
- P.E. PostmusPPP.E. Postmus
- E.G.E. De VriesEVE.G.E. De Vries
- H.G. De Vries-HospersHVH.G. De Vries-Hospers
- R. VriesendorpRVR. Vriesendorp
- G.W. Van ImhoffGIG.W. Van Imhoff
- J.J.M. HolthuisJHJ.J.M. Holthuis
- C.TH. Smit SibingaCSC.TH. Smit Sibinga
- D.TH. SleijferDSD.TH. Sleijfer
- N.H. MulderNMN.H. Mulder
- 1 June 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (6) , 777-782
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.Journal of Clinical Oncology, 1984
- Small cell lung cancer and the influence of chemotherapy on CFUcs in bone marrowCancer, 1984
- Autologous cryopreserved platelets and prophylaxis of bleeding in autologous bone marrow transplantationAnnals of Hematology, 1983
- Plasma assay for the antineoplastic agent VP 16-213 (etoposide) using high-performance liquid chromatography with electrochemical detectionJournal of Pharmaceutical and Biomedical Analysis, 1983
- AUTOLOGOUS BONE MARROW RESCUE IS UNNECESSARY AFTER VERY-HIGH-DOSE CYCLOPHOSPHAMIDEThe Lancet, 1983
- Enteral nutrition by nasogastric tube in adult patients treated with intensive chemotherapy for acute leukemiaThe American Journal of Clinical Nutrition, 1982
- Cardiotoxicity Associated With High-Dose Cyclophosphamide TherapyArchives of internal medicine (1960), 1981
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract1980